ArticleBMC microbiology2025
DNAJA2 inhibits Newcastle disease virus replication by targeting its V protein to modulate the MDA5-MAVS pathway.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAs a molecular chaperone of heat shock protein 70 (HSP70), DnaJ heat shock protein family member A2 (DNAJA2) can facilitate protein folding under stress conditions and has recently emerged as a novel and critical regulator that modulates the innate immune response. The V protein of Newcastle disease virus (NDV) is a crucial virulence factor; however, its relationship with the heat shock protein family remains poorly understood.
resultsWe identified the interaction between DNAJA2 and NDV V proteins through immunoprecipitation‒mass spectrometry (IP‒MS) and confirmed that this interaction occurred mainly at residues 101–367 aa of DNAJA2. This finding was further validated by confocal microscopy and coimmunoprecipitation (co-IP). We found that the expression level of DNAJA2 is elevated during NDV infection. The overexpression of DNAJA2 enhances the expression of melanoma differentiation-associated gene 5 (MDA5) and mitochondrial antiviral signaling protein (MAVS), which upregulate the production of interferon-stimulated genes (ISGs) and interferon-β (IFN-β), thereby inhibiting the replication of NDV. In contrast, DNAJA2 knockdown promoted viral replication.
conclusionsNotably, DNAJA2-mediated modulation of innate immunity occurred specifically in the presence of NDV or NDV V proteins, suggesting that DNAJA2 potentially activates immune signaling pathways by targeting the NDV V protein. These findings establish the role of DNAJA2 against NDV and combine the heat shock protein family with the innate immune pathway, providing new institutional insights into the relationship between the virus and the host and the prevention and control of the virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.